28-03-2013 дата публикации
Номер: US20130079308A1
The present invention provides β-hydroxy-γ-aminophosphonates, β-amino-γ-aminophosphonates, and analogs thereof that inhibit carnitine acyltransferases. The invention also provides compositions comprising these β-hydroxy-γ-aminophosphonates, β-amino-γ-aminophosphonates, and analogs, and methods of the use of such compounds and compositions in the treatment, amelioration or prevention of pathological conditions, diseases or disorders that are linked with fatty acid metabolism, such as non-insulin dependent diabetes or obesity. The invention also provides processes for the preparation of such compounds and compositions. 1114-. (canceled)121. (canceled)122. The method of claim 118 , further comprising administering to said patient one or more additional therapeutic agents.123. The method of claim 122 , wherein said one or more additional therapeutic agents is selected from the group consisting of anticholesterolemics claim 122 , anticoagulants claim 122 , anti-obesity or anti-diabetic drugs claim 122 , and combinations thereof.124. (canceled)125. The method of claim 118 , wherein said disorder or condition is selected from the group consisting of non-insulin dependent diabetes mellitus claim 118 , obesity claim 118 , hyperlipoproteinemia claim 118 , hyperlipidemia claim 118 , myocardial dysfunction claim 118 , renal anemia and Alzheimer's disease.126. The method of claim 125 , wherein said disorder or condition is non-insulin dependent diabetes.127. The method of claim 125 , wherein said disorder or condition is obesity.128. The method of claim 118 , wherein Z is O.129. The method of claim 128 , wherein:R is methyl;{'sup': '1', 'Ris selected from the group consisting of n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, benzyl, and phenyl;'}{'sup': 2', '3, 'Rand Rare independently selected from the group consisting hydrogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, isopenyl, benzyl, and phenyl; and'}{'sup': '4', 'Ris ...
Подробнее